Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Evidence-Based Complementary and Alternative Medicine : Ecam|August 17, 2017
Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency SyndromeFangfang Tao, Ping Lü, Chunbo Xu, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 8, 2019
Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in MalignanciesGuan Feng, Kaibo Guo, Qingying Yan, et al.Cancer Medicine|December 8, 2023
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: A systematic review and meta-analysisXin Gao, Ying Zhu, Peipei Wang, et al.The American Journal of Chinese Medicine|February 19, 2026
Research Progress of Traditional Chinese Medicine in Regulating Ferroptosis Related to Digestive System TumorsXinyu Cai, Xueer Zheng, Jiahua Mao, et al.Cancer Medicine|May 30, 2020
Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancerKaibo Guo, Yuqian Feng, Li Yuan, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|July 9, 2019
The Method of Activating Blood and Dredging Collaterals for Reducing Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-AnalysisZhaoyi Li, Huimin Jin, Qingying Yan, et al.Frontiers in Oncology|May 3, 2021
Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in TumorsKaibo Guo, Yuqian Feng, Xueer Zheng, et al.Molecular Medicine Reports|November 9, 2019
CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family membersKaibo Guo, Guan Feng, Qingying Yan, et al.Frontiers in Pharmacology|March 15, 2021
Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?Yuqian Feng, Huimin Jin, Kaibo Guo, et al.Journal of Cancer|October 2, 2018
Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolismShanming Ruan, Zhiqian Zhang, Xinxin Tian, et al.Pageof 4